Healthcare of Ontario Pension Plan Trust Fund grew its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 8.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 162,818 shares of the financial services provider’s stock after purchasing an additional 12,818 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund’s holdings in MetLife were worth $13,429,000 as of its most recent SEC filing.
Other hedge funds have also recently made changes to their positions in the company. PFG Investments LLC boosted its stake in shares of MetLife by 8.9% during the third quarter. PFG Investments LLC now owns 6,360 shares of the financial services provider’s stock valued at $525,000 after purchasing an additional 520 shares in the last quarter. M&G Plc acquired a new position in shares of MetLife in the second quarter worth approximately $2,346,000. B. Metzler seel. Sohn & Co. Holding AG acquired a new position in shares of MetLife in the third quarter worth approximately $2,960,000. PGGM Investments lifted its stake in shares of MetLife by 1,803.4% in the second quarter. PGGM Investments now owns 69,796 shares of the financial services provider’s stock worth $4,899,000 after acquiring an additional 66,129 shares during the period. Finally, Segall Bryant & Hamill LLC acquired a new position in shares of MetLife in the third quarter worth approximately $1,074,000. 89.81% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities analysts recently commented on the company. Bank of America cut their price objective on MetLife from $99.00 to $96.00 and set a “buy” rating on the stock in a research note on Thursday, August 1st. Barclays cut their price objective on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research note on Thursday, October 31st. Morgan Stanley lowered their target price on MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a report on Monday, August 19th. Wells Fargo & Company lifted their target price on MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a report on Tuesday, November 5th. Finally, Piper Sandler lifted their target price on MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Fourteen research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $88.62.
MetLife Trading Up 0.6 %
NYSE MET opened at $88.25 on Friday. The company has a market cap of $61.11 billion, a price-to-earnings ratio of 17.79, a P/E/G ratio of 0.81 and a beta of 1.05. MetLife, Inc. has a 52 week low of $62.89 and a 52 week high of $89.05. The business has a 50 day moving average price of $83.19 and a 200-day moving average price of $76.46. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51.
MetLife Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be issued a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 annualized dividend and a yield of 2.47%. MetLife’s dividend payout ratio (DPR) is currently 43.95%.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- Stock Analyst Ratings and Canadian Analyst Ratings
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Using the MarketBeat Dividend Yield Calculator
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Are Some of the Best Large-Cap Stocks to Buy?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.